Metformin Hydrochloride Clinical Trials

6 actively recruiting trials across 2 locations

No change since May 2026

Also known as: FICONAX, GLUCOPHAGE, Glucophage

Pipeline

Early 1: 1Phase 2: 3Phase 3: 1Phase 4: 1

Top Sponsors

University of Kansas Medical Center1
Istituto Ortopedico Rizzoli1
Instituto Nacional de Cancerologia de Mexico1
Fazaia Ruth Pfau Medical College1
Cairo University1

Indications

Cancer3
Diabetes2
Cystic Fibrosis-related Diabetes1
Gestational Diabetes1
Cystic Fibrosis1

Other4 trials

Efficacy of Metformin as an Adjunct to Standard Antidepressant Therapy in Treating Depression Among Obese Patients

Phase 4

Evaluation of the Chemo-preventive Effect of Combined Topical and Systemic Metformin on Oral Leukoplakia

Phase 2

Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations

Phase 3

Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse

Phase 2

Iowa City, Iowa1 trial

Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes

University of Iowa

Early 1

Kansas City, Kansas1 trial

Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function

University of Kansas Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.